TIFFANY LEE: Open Payments
NPI 1215307202 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 20 payments from 15 companies in 2025. Trend: 2023 $346 · 2024 $398 · 2025 $834
Food & beverage: $814Education: $20
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 3 | $201 |
| Travere Therapeutics, Inc. | 1 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $139 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| Alexion Pharmaceuticals, Inc. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Mannkind Corporation | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| Amgen Inc. | 1 | $22 |
Products named: TARPEYO, Filspari, Kerendia, GVOKE HYPOPEN, ULTOMIRIS, JARDIANCE, ACTHAR, AFREZZA.
Industry payments across NC — which companies pay providers there.
